Recombinant kallikrein expression: Site-specific integration for hK6 production in human cells

Biological Chemistry

Volumn 387, Issue 6, 2006, Pages 687-695

  Heuzé Vourc'h, Nathalie ^a,b,c   Aïnciburu, Mireille ^a,c   Planque, Chris ^a,c   Brillard Bourdet, Michèle ^a,c   Ott, Catherine ^d   Jolivet Reynaud, Colette ^d   Courty, Yves ^a,b,c  

^a INSERM   (France)

^b IFR 135 'Imagerie Fonctionnelle'   (France)

^c UNIVERSITÉ DE TOURS   (France)

^d BIOMÉRIEUX   (France)

Author keywords

Bioreactor; Human cells; Kallikrein; Recombinant proteins; Targeted integration of transgene

Indexed keywords

BIOLOGICAL MARKER; DNA; RECOMBINANT KALLIKREIN; RECOMBINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY DETECTION; BIOREACTOR; CANCER DIAGNOSIS; CARCINOGENESIS; CONFERENCE PAPER; ENZYME SPECIFICITY; ESCHERICHIA COLI; EVALUATION RESEARCH; FOLLOW UP; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; INSECT CELL; KALLIKREIN KININ SYSTEM; MAMMAL CELL; NONHUMAN; PATHOPHYSIOLOGY; PICHIA PASTORIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING;

CELL LINE; CLONING, MOLECULAR; HUMANS; KALLIKREINS; RECOMBINANT PROTEINS; RECOMBINATION, GENETIC;

EID: 33745665355     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2006.087     Document Type: Conference Paper

References (51)

1. Angermann, A., Bergmann, C., and Appelhans, H. (1989). Cloning and expression of human salivary-gland kallikrein in Escherichia coli. Biochem. J. 262, 787-793.
2. Angermann, A., Rahn, H.P., Hekto, T., Fertig, G., and Kemme, M. (1992). Purification and characterization of human salivary-gland prokallikrein from recombinant baculovirus-infected insect cells. Eur. J. Biochem. 206, 225-233.
3. Baneyx, F. (1999). Recombinant protein expression in Escherichia coli. Curr. Opin. Biotechnol. 10, 411-421.
4. Barnes, L.M., Bentley, C.M., and Dickson, A.J. (2003). Stability of protein production from recombinant mammalian cells. Biotechnol. Bioeng. 81, 631-639.
5. Bayes, A., Tsetsenis, T., Ventura, S., Vendrell, J., Aviles, F.X., and Sotiropoulou, G. (2004). Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation/inactivation. Biol. Chem. 385, 517-524.
6. Bernett, M.J., Blaber, S.I., Scarisbrick, I.A., Dhanarajan, P., Thompson, S.M., and Blaber, M. (2002). Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system. J. Biol. Chem. 277, 24562-24570.
7. Borgoño, C.A. and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer 4, 876-890.
8. Borgoño, C.A., Grass, L., Soosaipillai, A., Yousef, G.M., Petraki, C.D., Howarth, D.H.C., Fracchioli, S., Katsaros, D., and Diamandis, E.P. (2003). Human kallikrein 14: a new potential biomarker for ovarian and breast cancer. Cancer Res. 63, 9032-9041.
9. Brattsand, M. and Egelrud, T. (1999). Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation. J. Biol. Chem. 274, 30033-30040.
10. Clark, E. (1998). Refolding of recombinant proteins. Curr. Opin. Biotechnol. 9, 157-163.
11. Daly, R. and Hearn, M.T.W. (2005). Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production. J. Mol. Recognit. 18, 119-138.
12. Eerola, R., Piironen, T., Pettersson, K., Lovgren, J., Vehniainen, M., Lilja, H., Dowell, B., Lovgren, T., and Karp, M. (1997). Immunoreactivity of recombinant human glandular kallikrein using monoclonal antibodies raised against prostate-specific antigen. Prostate 31, 84-90.
13. Ekholm, I.E., Brattsand, M., and Egelrud, T. (2000). Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process? J. Invest. Dermatol. 114, 56-63.
14. Fortier, A.H., Holaday, J.W., Liang, H., Dey, C., Grella, D.K., Holland-Linn, J., Vu, H., Plum, S.M., and Nelson, B.J. (2003). Recombinant prostate specific antigen inhibits angiogenesis in vitro and in vivo. Prostate 56, 212-219.
15. Habeck, L.L., Belagaje, R.M., Becker, G.W., Hale, J.E., Churgay, L.M., Ulmer, M., Yang, X.Y., Shackelford, K.A., Richardson, J.M., Johnson, M.G., and Mendelsohn, L.G. (2001). Expression, purification, and characterization of active recombinant prostate-specific antigen in Pichia pastoris (yeast). Prostate 46, 298-306.
16. Hansson, L., Stromqvist, M., Backman, A., Wallbrandt, P., Carlstein, A., and Egelrud, T. (1994). Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase. J. Biol. Chem. 269, 19420-19426.
17. Huang, X., Knoell, C.T., Frey, G., Hazegh-Azam, M., Tashjian, A.H.J., Hedstrom, L., Abeles, R.H., and Timasheff, S.N. (2001). Modulation of recombinant human prostate-specific antigen: activation by Hofmeister salts and inhibition by azapeptides. Appendix: thermodynamic interpretation of the activation by concentrated salts. Biochemistry 40, 11734-11741.
18. Kapadia, C., Chang, A., Sotiropoulou, G., Yousef, G.M., Grass, L., Soosaipillai, A., Xing, X., Howarth, D.H.C., and Diamandis, E.P. (2003). Human kallikrein 13: production and purification of recombinant protein and monoclonal and polyclonal antibodies, and development of a sensitive and specific immunofluorometric assay. Clin. Chem. 49, 77-86.
19. Karr, J.F., Kantor, J.A., Hand, P.H., Eggensperger, D.L., and Schlom, J. (1995). The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line. Cancer Res. 55, 2455-2462.
20. Katz, B.A., Liu, B., Barnes, M., and Springman, E.B. (1998). Crystal structure of recombinant human tissue kallikrein at 2.0 Å resolution. Protein Sci. 7, 875-885.
21. Kishi, T., Kato, M., Shimizu, T., Kato, K., Matsumoto, K., Yoshida, S., Shiosaka, S., and Hakoshima, T. (1997). Crystallization and preliminary X-ray analysis of neuropsin, a serine protease expressed in the limbic system of mouse brain. J. Struct. Biol. 118, 248-251.
22. Kishi, T., Grass, L., Soosaipillai, A., Shimizu-Okabe, C., and Diamandis, E.P. (2003). Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids. Clin. Chem. 49, 87-96.
23. Kishi, T., Soosaipillai, A., Grass, L., Little, S.P., Johnstone, E.M., and Diamandis, E.P. (2004). Development of an immunofluorometric assay and quantification of human kallikrein 7 in tissue extracts and biological fluids. Clin. Chem. 50, 709-716.
24. Kumar, A., Goel, A.S., Hill, T.M., Mikolajczyk, S.D., Millar, L.S., Kuus-Reichel, K., and Saedi, M.S. (1996). Expression of human glandular kallikrein, hK2, in mammalian cells. Cancer Res. 56, 5397-5402.
25. Kumar, A., Goel, A.S., Payne, J.K., Evans, C., Mikolajczyk, S.D., Kuus-Reichel, K., and Saedi, M.S. (1999). Large-scale propagation of recombinant adherent cells that secrete a stable form of human glandular kallikrein, hK2. Protein Expr. Purif. 15, 62-68.
26. Kurkela, R., Herrala, A., Henttu, P., Nai, H., and Vihko, P. (1995). Expression of active, secreted human prostate-specific antigen by recombinant baculovirus-infected insect cells on a pilot-scale. Biotechnology 13, 1230-1234.
27. Laxmikanthan, G., Blaber, S.I., Bernett, M.J., Scarisbrick, I.A., Juliano, M.A., and Blaber, M. (2005). 1.70 Å X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding. Proteins 58, 802-814.
28. Lovgren, J., Piironen, T., Overmo, C., Dowell, B., Karp, M., Pettersson, K., Lilja, H., and Lundwall, A. (1995). Production of recombinant PSA and HK2 and analysis of their immunologic cross-reactivity. Biochem. Biophys. Res. Commun. 213, 888-895.
29. Lovgren, J., Rajakoski, K., Karp, M., and Lilja, H. (1997). Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2. Biochem. Biophys. Res. Commun. 238, 549-555.
30. Lovgren, J., Tian, S., Lundwall, A., Karp, M., and Lilja, H. (1999). Production and activation of recombinant hK2 with propeptide mutations resulting in high expression levels. Eur. J. Biochem. 266, 1050-1055.
31. Lu, H.S., Hsu, Y.R., Lu, L.I., Ruff, D., Lyons, D., and Lin, F.K. (1996). Isolation and characterization of human tissue kallikrein produced in Escherichia coli: biochemical comparison to the enzymatically inactive prokallikrein and methionyl kallikrein. Protein Expr. Purif. 8, 215-226.
32. Lundstrom, K. (2003). Semliki Forest virus vectors for rapid and high-level expression of integral membrane proteins. Biochim. Biophys. Acta 1610, 90-96.
33. Luo, L.Y., Grass, L., Howarth, D.J., Thibault, P., Ong, H., and Diamandis, E.P. (2001). Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues. Clin. Chem. 47, 237-246.
34. Magklara, A., Mellati, A.A., Wasney, G.A., Little, S.P., Sotiropoulou, G., Becker, G.W., and Diamandis, E.P. (2003). Characterization of the enzymatic activity of human kallikrein 6: autoactivation, substrate specificity, and regulation by inhibitors. Biochem. Biophys. Res. Commun. 307, 948-955.
35. Matsumura, M., Bhatt, A.S., Andress, D., Clegg, N., Takayama, T.K., Craik, C.S., and Nelson, P.S. (2005). Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries. Prostate 62, 1-13.
36. Mergulhao, F.J.M., Summers, D.K., and Monteiro, G.A. (2005). Recombinant protein secretion in Escherichia coli. Biotechnol. Adv. 23, 177-202.
37. Michael, I.P., Sotiropoulou, G., Pampalakis, G., Magklara, A., Ghosh, M., Wasney, G., and Diamandis, E.P. (2005). Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression. J. Biol. Chem. 280, 14628-14635.
38. Mitsui, S., Yamada, T., Okui, A., Kominami, K., Uemura, H., and Yamaguchi, N. (2000). A novel isoform of a kallikrein-like protease, TLSP/hippostasin, (PRSS20), is expressed in the human brain and prostate. Biochem. Biophys. Res. Commun. 272, 205-211.
39. Obiezu, C.V., Soosaipillai, A., Jung, K., Stephan, C., Scorilas, A., Howarth, D.H.C., and Diamandis, E.P. (2002). Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry. Clin. Chem. 48, 1232-1240.
40. Saedi, M.S., Cass, M.M., Goel, A.S., Grauer, L., Hogen, K.L., Okaneya, T., Griffin, B.Y., Klee, G.G., Young, C.Y., and Tindall, D.J. (1995). Overexpression of a human prostate-specific glandular kallikrein, hK2, in E. coli and generation of antibodies. Mol. Cell. Endocrinol. 109, 237-241.
41. Saedi, M.S., Zhu, Z., Marker, K., Liu, R.S., Carpenter, P.M., Rittenhouse, H., and Mikolajczyk, S.D. (2001). Human kallikrein 2 (hK2), but not prostate-specific antigen (PSA), rapidly complexes with protease inhibitor 6 (PI-6) released from prostate carcinoma cells. Int. J. Cancer 94, 558-563.
42. Schmidt, F.R. (2004). Recombinant expression systems in the pharmaceutical industry. Appl. Microbiol. Biotechnol. 65, 363-372.
43. Shinmura, K., Tao, H., Yamada, H., Kataoka, H., Sanjar, R., Wang, J., Yoshimura, K., and Sugimura, H. (2004). Splice-site genetic polymorphism of the human kallikrein 12 (KLK12) gene correlates with no substantial expression of KLK12 protein having serine protease activity. Hum. Mutat. 24, 273-274.
44. Takayama, T.K., Fujikawa, K., and Davie, E.W. (1997). Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein. J. Biol. Chem. 272, 21582-21588.
45. Takayama, T.K., Carter, C.A., and Deng, T. (2001a). Activation of prostate-specific antigen precursor (pro-PSA) by prostin, a novel human prostatic serine protease identified by degenerate PCR. Biochemistry 40, 1679-1687.
46. Takayama, T.K., McMullen, B.A., Nelson, P.S., Matsumura, M., and Fujikawa, K. (2001b). Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase. Biochemistry 40, 15341-15348.
47. Thyagarajan, B. and Calos, M.P. (2005). Site-specific integration for high-level protein production in mammalian cells. Methods Mol. Biol. 308, 99-106.
48. Wurm, F.M. (2004). Production of recombinant protein therapeutics in cultivated mammalian cells. Nat. Biotechnol. 22, 1393-1398.
49. Yousef, G.M. and Diamandis, E.P. (2001). The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev. 22, 184-204.
50. Yousef, G.M., Kapadia, C., Polymeris, M., Borgono, C., Hutchinson, S., Wasney, G.A., Soosaipillai, A., and Diamandis, E.P. (2003a). The human kallikrein protein 5 (hK5) is enzymatically active, glycosylated and forms complexes with two protease inhibitors in ovarian cancer fluids. Biochim. Biophys. Acta 1628, 88-96.
51. Yousef, G.M., Polymeris, M., Grass, L., Soosaipillai, A., Chan, P., Scorilas, A., Borgono, C., Harbeck, N., Schmalfeldt, B., Dorn, J., et al. (2003b). Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer. Cancer Res. 63, 3958-3965.